Photo: Medicen Paris Region

Prepared for the time after COVID-19

Medicen Paris Region, the health innovation hub in Île-de-France, announces the appointment of Jessica Leygues as CEO.

She joins Medicen in difficult times. It will be the task of the health cluster to implement COVID-crisis exit strategies for cluster members and the health sector. But Jessica Leygues is well prepared. Leygues, a graduate in engineering from the Paris Institute of Technology for Life, Food and Environmental Sciences (AgroParisTech), started her career at the Alcimed consulting firm. There, she spent eight years developing new healthcare markets (biotech/medtech) for entrepreneurs, start-ups, SMEs and large corporations as well as for the public and parapublic innovation sector, including the French Ministry of Research, research institutes, competitiveness clusters and knowledge transfer centers. Then Leygues joined the pharmaceutical company Celgene, where she was responsible for an innovative partnership hub aimed at developing the healthcare value model.

 “I am delighted to join Medicen, at a key point in time when the cluster’s priorities need to be reassessed, as required after the COVID-19 pandemic. Close dialogue must be encouraged with teams, governance and all stakeholders within the Île-de-France region,” said Leygues. “We will need to initiate concrete reindustrialization projects to aid growth and rebuild national sovereignty for the healthcare industry. In particular, we will support micro businesses and SMEs through a groundbreaking, innovative dynamic for healthcare priorities and as part of an open approach to European ecosystems.”